Indaptus Therapeutics, Inc. held its Annual Meeting where stockholders approved an amendment and restatement of the Company's 2021 Stock Incentive Plan and elected three Class III directors.
AI Assistant
INDAPTUS THERAPEUTICS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.